Dr. Cecilia Olugbade-oseyemi, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 208 Upland Rd, Merion Station, PA 19066 Phone: 610-668-4014 |
News Archive
A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.
There's no doubt estrogen plays a big role in the differences between males and females, and now researchers want to know if it also helps explain emerging sex differences in what makes younger, obese men and women hypertensive.
Since the sequence map of the human genome, the cost of sequencing the genome of an individual has fallen rapidly. This has resulted in a tremendous increase in the amount of human genomic data available to the international research community for the advancement of biomedical research. Yet, there is an absence of international mechanisms to support researchers in ensuring ethical and legal interoperability. In addition, the multiplicity and diversity of laws, standards and policies on sharing and accessing genetic and medical data represent major hurdles to international collaboration.
NASA has signed a patent license agreement with a California company to improve the medical community's access to hyperbaric chambers used to treat many medical conditions and emergencies. OxyHeal Medical Systems Inc. of National City, Calif., will develop new products based on technologies NASA originally developed for space.
› Verified 5 days ago